Bruno David
Lourenço Paiva
Investigador en el periodo 2011-2015
United States Food and Drug Administration
Silver Spring, Estados UnidosPublicaciones en colaboración con investigadores/as de United States Food and Drug Administration (3)
2021
-
Minimal residual disease in Myeloma: Application for clinical care and new drug registration
Clinical Cancer Research, Vol. 27, Núm. 19, pp. 5195-5212
2014
-
Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium
American Journal of Hematology
2010
-
Human peripheral blood B-Cell compartments: A crossroad in B-cell traffic
Cytometry Part B - Clinical Cytometry, Vol. 78, Núm. SUPPL. 1